Duration of HAART use: A key prognosticator for NAFLD in HAART experienced HIV patients
Crossref DOI link: https://doi.org/10.30574/gscarr.2022.10.3.0077
Published Online: 2022-03-30
Update policy: https://doi.org/10.30574/gscarr.ourcrossmarkpolicy
Abere Sarah,
Oyan Boma,
